H-1B sponsorship profile: Nurix Therapeutics, Inc. Across U.S. Department of Labor LCA disclosures, Nurix Therapeutics, Inc filed 42 Labor Condition Applications covering 42 H-1B worker positions between fiscal year 2023 and fiscal year 2026. The employer’s DOL certification rate sits at 97.6% (41 certified of 42 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Nurix Therapeutics, Inc’s H-1B petitions range from $60,000 at the low end to $225,000 at the high end, with a petition-weighted average of $127,107. That range reflects the mix of occupations the company sponsors, led by Scientist II, Discovery Immunology (4 petitions at $130,000 avg), followed by Medicinal Chemistry Contractor and Senior Research Associate. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Nurix Therapeutics, Inc is headquartered in San Francisco, CA under NAICS code 541714, and places H-1B workers across 3 states, most heavily in CA, MD, TX. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Nurix Therapeutics, Inc ranks. By H-1B petition volume, Nurix Therapeutics, Inc is #5,485 of 119,880 employers nationally and #800 of 22,893 employers headquartered in CA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.